1. AB0692 Effects of intravenous golimumab on patient-reported outcomes in active ankylosing spondylitis: 28-week results of the phase III go-alive trial. (15th June 2017) Authors: Reveille, JD; Deodhar, A; Chan, EK; Peterson, S; Li, N; Hsia, E; Kim, L; Lo, KH; Harrison, DD; Han, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Issue 3 (3rd December 2010) Authors: Diaz-Gallo, LM; Gourh, P; Broen, J; Simeon, C; Fonollosa, V; Ortego-Centeno, N; Agarwal, S; Vonk, MC; Coenen, M; Riemekasten, G; Hunzelmann, N; Hesselstrand, R; Tan, FK; Reveille, JD; Assassi, S; García-Hernandez, FJ; Carreira, P; Camps, MT; Fernandez-Nebro, A; de la Peña, P Garcia Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 3(2011) Page Start: 454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP0031 Genetic studies in familial ankylosing spondylitis: the north american spondylitis consortium experience. (1st June 2001) Authors: Reveille, JD; Bruckel, J; Inman, R; Weisman, M; Khan, MA; Yu, DTK; Schumacher, R; Mahowald, M; Sawitzke, A; Stone, M; Vasey, F; Akey, J; Jin, L Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0348 Safety and efficacy of intravenous golimumab in adult patients with active ankylosing spondylitis: results through week 28. (15th June 2017) Authors: Deodhar, A; Reveille, JD; Harrison, DD; Kim, L; Lo, KH; Hsia, E Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0360 Improvements in sleep problems and pain in patients with active ankylosing spondylitis treated with intravenous golimumab: 28-week results of the phase iii go-alive trial. (15th June 2017) Authors: Deodhar, A; Reveille, JD; Chan, EK; Peterson, S; Li, N; Hsia, E; Kim, L; Lo, KH; Harrison, DD; Han, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗